These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 29382384)
21. A role for NF-kappaB-dependent gene transactivation in sunburn. Abeyama K; Eng W; Jester JV; Vink AA; Edelbaum D; Cockerell CJ; Bergstresser PR; Takashima A J Clin Invest; 2000 Jun; 105(12):1751-9. PubMed ID: 10862790 [TBL] [Abstract][Full Text] [Related]
22. Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides. Farahmand L; Darvishi B; Majidzadeh-A K Drug Deliv; 2017 Nov; 24(1):1249-1261. PubMed ID: 28870118 [TBL] [Abstract][Full Text] [Related]
23. Influence of pentylenetetrazol and NF-κB decoy oligodeoxynucleotides on p38 expression in neuron-like cells. Yang JJ; Li WH; Liu BJ; Tang RH; Zhang YH Exp Ther Med; 2014 Aug; 8(2):395-400. PubMed ID: 25009589 [TBL] [Abstract][Full Text] [Related]
24. [Nuclear localization of oligonucleotides decoy effect on nuclear factor-kappaB activity]. Liu Y; Quan F; Wang J; Bai X Sheng Wu Gong Cheng Xue Bao; 2010 Dec; 26(12):1683-9. PubMed ID: 21387831 [TBL] [Abstract][Full Text] [Related]
25. [An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell]. Hao TZ; Liang HP; Lv FL; Xu X; Guo H; Wang FL; Yang WJ; Luo Y; Li L Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):175-8. PubMed ID: 12921625 [TBL] [Abstract][Full Text] [Related]
26. Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus. Osako MK; Tomita N; Nakagami H; Kunugiza Y; Yoshino M; Yuyama K; Tomita T; Yoshikawa H; Ogihara T; Morishita R J Gene Med; 2007 Sep; 9(9):812-9. PubMed ID: 17640082 [TBL] [Abstract][Full Text] [Related]
27. Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. Bezzerri V; Borgatti M; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Rizzotti P; Gambari R; Cabrini G Am J Respir Cell Mol Biol; 2008 Jul; 39(1):86-96. PubMed ID: 18258920 [TBL] [Abstract][Full Text] [Related]
28. [Effect of AP-1 decoy oligodeoxynucleotides on neonatal rat cardiac fibroblast proliferation and collagen synthesis]. Xie SL; Wang JF; Nie RQ; Yuan WL; Li F; Lin MH Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):811-4. PubMed ID: 18504209 [TBL] [Abstract][Full Text] [Related]
29. Design and characterization of decoy oligonucleotides containing locked nucleic acids. Crinelli R; Bianchi M; Gentilini L; Magnani M Nucleic Acids Res; 2002 Jun; 30(11):2435-43. PubMed ID: 12034831 [TBL] [Abstract][Full Text] [Related]
30. Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides. Jiang H; Hu H; Zhang Y; Yue P; Ning L; Zhou Y; Shi P; Yuan R Drug Des Devel Ther; 2017; 11():2997-3007. PubMed ID: 29075103 [TBL] [Abstract][Full Text] [Related]
31. Potential protective effect of nuclear factor-κB decoy oligodeoxynucleotides on endotoxin-induced liver injury. Li JD; Peng Y; Li Q; Xiao JW; Gong JP; Liu ZJ Transplant Proc; 2011 Dec; 43(10):3613-7. PubMed ID: 22172814 [TBL] [Abstract][Full Text] [Related]
32. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells]. Lu JP; Sun H; Cao CC; Ou ZL Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352 [TBL] [Abstract][Full Text] [Related]
33. Molecular stripping, targets and decoys as modulators of oscillations in the NF-κB/IκBα/DNA genetic network. Wang Z; Potoyan DA; Wolynes PG J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27683001 [TBL] [Abstract][Full Text] [Related]
34. Transfection of naked nuclear factor-κB decoy oligodeoxynucleotides into liver by rapid portal vein infusion in rats: its effect on ischemia-reperfusion injury of liver. Watanabe G; Uchinami H; Yoshioka M; Abe Y; Kikuchi I; Iwasaki W; Kume M; Yamamoto Y Hum Gene Ther; 2012 Apr; 23(4):428-36. PubMed ID: 22397701 [TBL] [Abstract][Full Text] [Related]
35. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo. Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290 [TBL] [Abstract][Full Text] [Related]
36. Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice. He F; Li WN; Li XX; Yue KY; Duan JL; Ruan B; Liu JJ; Song P; Yue ZS; Tao KS; Wang L Theranostics; 2022; 12(4):1816-1828. PubMed ID: 35198075 [No Abstract] [Full Text] [Related]
37. Application of Transcription Factor Decoy Oligodeoxynucleotides (ODNs) for Cancer Therapy. Johari B; Moradi M Methods Mol Biol; 2022; 2521():207-230. PubMed ID: 35733000 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo. Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376 [TBL] [Abstract][Full Text] [Related]
39. Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules. Crinelli R; Carloni E; Menotta M; Giacomini E; Bianchi M; Ambrosi G; Giorgi L; Magnani M ACS Nano; 2010 May; 4(5):2791-803. PubMed ID: 20411956 [TBL] [Abstract][Full Text] [Related]
40. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]